Alkem Laboratories Limited (BOM:539523)
4,605.65
-121.40 (-2.57%)
At close: Feb 21, 2025
Alkem Laboratories Revenue
Alkem Laboratories had revenue of 33.74B INR in the quarter ending December 31, 2024, with 1.52% growth. This brings the company's revenue in the last twelve months to 127.57B, up 0.97% year-over-year. In the fiscal year ending March 31, 2024, Alkem Laboratories had annual revenue of 126.68B with 9.21% growth.
Revenue (ttm)
127.57B
Revenue Growth
+0.97%
P/S Ratio
n/a
Revenue / Employee
7.32M
Employees
17,432
Market Cap
550.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
Mar 31, 2021 | 88.65B | 5.21B | 6.24% |
Mar 31, 2020 | 83.44B | 9.87B | 13.42% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,702.59B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 1,755.26B |
Infosys | 1,635.60B |
State Bank of India | 3,409.52B |
Hindustan Unilever | 626.61B |
Alkem Laboratories News
- 15 days ago - Alkem Laboratories Ltd (BOM:539523) Q3 2025 Earnings Call Highlights: Strategic Acquisitions ... - GuruFocus
- 15 days ago - Q3 2025 Alkem Laboratories Ltd Earnings Call Transcript - GuruFocus
- 16 days ago - Alkem Laboratories acquires 100% stake in Adroit Biomed for Rs 140 crore - Business Upturn
- 16 days ago - Alkem Laboratories shares drop 3% as revenue growth remains flat at Rs 3374 crore in Q3 - Business Upturn
- 16 days ago - Alkem Laboratories Q3 FY25 Results: Revenue flat at Rs 3374 crore, Profit up 6% YoY - Business Upturn
- 19 days ago - Alkem Laboratories launches Kojiglo serum for facial hyperpigmentation in India - Business Upturn
- 4 weeks ago - Pharma stocks: Glenmark up 1.57%, Glaxo gains 1.31%, Mankind Pharma declines 2.84% - Business Upturn
- 5 weeks ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn